Finance

Lists
Why is INM up 3,44%?
Dive Deeper
INM:NASDAQ
InMed Pharmaceuticals Inc
1,37 USD
+3,44%
(+0,045) 1D
1,36 USD
-0,40% (-0,0054)
After hours
Closed: 19-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INM...
Open
1,32 USD
High
1,39 USD
Low
1,32 USD
Mkt. cap
7,50 млн
Avg. vol.
52,57 миң
Volume
38,47 миң
52-wk high
2,33 USD
52-wk low
0,58 USD
EPS
-2,73 USD
Beta
0,93
Shares outstanding
5,49 млн
No. of employees
6
Open
1,32 USD
High
1,39 USD
Low
1,32 USD
Mkt. cap
7,50 млн
Avg. vol.
52,57 миң
Volume
38,47 миң
52-wk high
2,33 USD
52-wk low
0,58 USD
EPS
-2,73 USD
Beta
0,93
Shares outstanding
5,49 млн
No. of employees
6
News stories
From web sources and news partners
About InMed Pharmaceuticals Inc
CEOEric A. Adams
Employees6
Founded1981
HeadquartersВанкувер, Бритиш Колумбия, Канада
SectorPharmaceutical industry
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,12 млн
820,19 миң
-
-
Cost of goods sold
716,96 миң
635,99 миң
-
-
Cost of revenue
716,96 миң
635,99 миң
-
-
Research and development expenses
581,61 миң
630,64 миң
1,02 млн
805,74 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,53 млн
1,62 млн
1,74 млн
2,36 млн
Operating expense
2,17 млн
2,30 млн
2,82 млн
3,21 млн
Total operating expenses
2,88 млн
2,94 млн
2,82 млн
3,21 млн
Operating income
-1,76 млн
-2,12 млн
-2,82 млн
-3,21 млн
Other non operating income
-
-
-
-
EBT including unusual items
-1,73 млн
-2,03 млн
-2,79 млн
-4,84 млн
EBT excluding unusual items
-1,73 млн
-2,03 млн
-2,79 млн
-3,19 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,73 млн
-2,03 млн
-2,97 млн
-5,84 млн
Net profit margin
-154,17%
-247,29%
-
-
Earnings per share
-
-
-
-
Interest and investment income
93,76 миң
74,38 миң
47,77 миң
29,06 миң
Interest expense
-
-
-
-10,70 миң
Net interest expenses
93,76 миң
74,38 миң
47,77 миң
18,36 миң
Depreciation and amortization charges
53,20 миң
53,20 миң
51,71 миң
48,36 миң
EBITDA
-1,71 млн
-2,07 млн
-2,77 млн
-3,16 млн
Gain or loss from assets sale
-
-
-
7,14 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору